TAYLOR DEVICES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TAYLOR DEVICES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $46.29M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $44.58M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $40.20M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $30.87M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $22.51M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $28.38M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $33.62M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $24.36M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $25.54M | Aug 29, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | May 31, 2017 | $25.54M | Aug 29, 2017 |
| FY2017 | May 31, 2016 | $35.68M | Aug 29, 2017 |
| FY2016 | May 31, 2015 | $30.59M | Aug 29, 2016 |
| FY2015 | May 31, 2014 | $20.01M | Aug 27, 2015 |
| FY2014 | May 31, 2013 | $24.73M | Aug 29, 2014 |
| FY2013 | May 31, 2012 | $29.01M | Aug 29, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $21.48M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $20.84M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $16.95M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $9.63M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $3.17M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $9.24M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $9.05M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $5.92M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $7.99M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $12.44M | Aug 29, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $9.41M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $9.00M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $6.29M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $2.24M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $1.06M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $3.03M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $2.54M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $443.4K | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $2.33M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $4.21M | Aug 29, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $9.63M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $9.48M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $6.81M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $2.47M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | ($2.35M) | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $3.30M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $3.00M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $647.6K | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $2.92M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $5.75M | Aug 29, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $444.0K | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $388.5K | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $1.10M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $999.2K | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $924.0K | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $585.0K | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $319.0K | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $263.0K | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $903.0K | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $428.0K | Aug 29, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $11.41M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $10.97M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $9.04M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $6.15M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $5.53M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $5.93M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $6.05M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $5.28M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $5.07M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $6.69M | Aug 29, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $7.47M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $13.22M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $7.71M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $3.31M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $7.03M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $9.83M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $2.66M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $304.5K | Aug 2, 2019 |
| FY2018 | May 31, 2017 | ($1.06M) | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $3.79M | Aug 29, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $2.60M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $1.15M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $3.36M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $1.39M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $1.62M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $1.23M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $472.8K | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $936.8K | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $1.87M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | ($1.94M) | Aug 29, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $71.62M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $63.08M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $57.88M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $49.22M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $45.93M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $45.08M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $41.20M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $39.51M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $37.16M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $36.81M | Aug 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $62.04M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $51.25M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $50.09M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $43.26M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $40.80M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $39.54M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $36.32M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $33.61M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $32.86M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $30.16M | Aug 29, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $60.54M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $51.13M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $42.13M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $35.84M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $33.60M | Aug 19, 2022 |
| FY2021 | May 31, 2020 | $32.54M | Aug 27, 2021 |
| FY2020 | May 31, 2019 | $29.51M | Aug 7, 2020 |
| FY2019 | May 31, 2018 | $26.96M | Aug 2, 2019 |
| FY2018 | May 31, 2017 | $26.52M | Aug 29, 2018 |
| FY2017 | May 31, 2016 | $24.19M | Aug 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | $1.19M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | $2.83M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | $3.58M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | $22.52M | Aug 15, 2023 |
| FY2022 | May 31, 2021 | $20.58M | Aug 19, 2022 |
| FY2022 | May 31, 2020 | $15.16M | Aug 19, 2022 |
| FY2021 | May 31, 2019 | $5.07M | Aug 27, 2021 |
| FY2020 | May 31, 2018 | $2.86M | Aug 7, 2020 |
| FY2019 | May 31, 2017 | $3.32M | Aug 2, 2019 |
| FY2018 | May 31, 2016 | $6.09M | Aug 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | May 31, 2012 | ($3.7K) | Aug 29, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 3 | Aug 15, 2025 |
| FY2025 | May 31, 2024 | 2 | Aug 15, 2025 |
| FY2024 | May 31, 2023 | 1 | Aug 15, 2024 |
| FY2023 | May 31, 2022 | 0 | Aug 15, 2023 |
| FY2022 | May 31, 2021 | 0 | Aug 19, 2022 |
| FY2018 | May 31, 2018 | 0 | Aug 29, 2018 |
| FY2018 | May 31, 2017 | 0 | Aug 29, 2018 |
| FY2017 | May 31, 2016 | 1 | Aug 29, 2017 |
| FY2016 | May 31, 2015 | 0 | Aug 29, 2016 |
| FY2015 | May 31, 2014 | 0 | Aug 27, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 2 | Aug 15, 2025 |
| FY2025 | May 31, 2024 | 2 | Aug 15, 2025 |
| FY2024 | May 31, 2023 | 1 | Aug 15, 2024 |
| FY2023 | May 31, 2022 | 0 | Aug 15, 2023 |
| FY2018 | May 31, 2018 | 0 | Aug 29, 2018 |
| FY2018 | May 31, 2017 | 0 | Aug 29, 2018 |
| FY2017 | May 31, 2016 | 1 | Aug 29, 2017 |
| FY2016 | May 31, 2015 | 0 | Aug 29, 2016 |
| FY2015 | May 31, 2014 | 0 | Aug 27, 2015 |
| FY2014 | May 31, 2013 | 0 | Aug 29, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 31, 2025 | 4.20M | Aug 15, 2025 |
| FY2025 | May 31, 2024 | 4.17M | Aug 15, 2025 |
| FY2024 | May 31, 2023 | 4.09M | Aug 15, 2024 |
| FY2023 | May 31, 2022 | 4.06M | Aug 15, 2023 |